妊娠各期孕妇体部CT检查的胎儿剂量评估
该研究提出一种基于z轴剂量分布的胎儿剂量评估方法,无需蒙特卡洛模拟即可计算孕妇胸部、腹部及腹盆部CT检查的胎儿平均剂量。在24例孕妇和3个妊娠模型验证中,该方法与蒙特卡洛模拟的胎儿剂量差异在5.8%至8.8%之间。结论认为,考虑母体体型、胎儿大小和位置以及胎儿是否位于扫描范围内,可实际用于体部CT的胎儿剂量计算。
要点
- 基于z轴剂量分布可替代蒙特卡洛模拟计算胎儿剂量。
- 计算需考虑CTDIvol、扫描范围、mA及胎儿质心处母体水当量直径。
- 胎儿完全在扫描野外、部分在野内或完全在野内时均适用。
局限性
- 验证样本量有限,仅24例孕妇和3个妊娠体模。
- 方法依赖z轴剂量分布计算,可能受扫描参数和患者体型变化影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: CTDIvol-to-fetal-dose coefficients from Monte Carlo simulations are useful for fetal dose evaluations, but the available data is limited to the fetus being completely inside the abdominopelvic scan range. Whereas in a chest examination, the fetus is completely outside the scan range. In an abdominal examination, the fetus after 16 gestational weeks is partly in the scan region, and an earlier fetus is completely outside of it. This work proposes a practical approach to evaluate fetal dose for pregnant patients undergoing body CT examinations, without using Monte Carlo simulation.
METHODS: The proposed method was based on the z-axis dose profile computed for a CT examination, considering CTDIvol, scan range, mA, and maternal WED (water equivalent diameter) at the fetus centroid. Fetal average dose was calculated over the fetus z-axis coverage. For validation, we considered a reference dataset of 24 pregnant patients, each underwent two abdominopelvic examinations (fixed mA, tube current modulation). WED was 30.1 ± 3.3 (25.3-35.6) cm [mean(range)]. Gestational age was <5 weeks for one patient, and 20.3 ± 9.1 (5-35.9) weeks for the others. Fetal depth (from the anterior skin surface to the most anterior part of fetus) was 6.1 ± 2.1 (2.5-10.9) cm. We further considered three whole-body models of a pregnant patient (gestational age, 3, 6, 9 months; weight, 62-73 kg) undergoing chest, abdominal, and abdominopelvic examinations (fixed mA). For the patients and models, profile-based fetal dose calculations were compared with the results of Monte Carlo simulations. Statistical software (R, version 3.5.1) was used to determine the mean and 95th percentile.
RESULTS: The fetal dose difference between profile-based evaluations and Monte Carlo simulations was (5.9 ± 3.8)% for 24 fixed-mA examinations, (5.8 ± 4.6)% for 24 tube current modulated examinations, and (8.8 ± 5.9)% for the whole-body models in three scan ranges.
CONCLUSIONS: Profile-based fetal dose calculations can be performed for patients in body CT, considering maternal size, fetus size and location, and whether fetus is completely inside, partly inside, or outside scan ranges.
引用
- Li X, Yang K, Westra SJ, et al. Fetal dose evaluation for body CT examinations of pregnant patients during all stages of pregnancy. Eur J Radiol. 2021. PMID: 34049058. doi:10.1016/j.ejrad.2021.109780
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。